Junichi Kurebayashi
5PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 27, 2021
A follow-up study of a randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-month depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer.Junichi Kurebayashi, Eiichi Shiba, Tatsuya Toyama
|Aug 30, 2020
Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells.Ryohei Ogata, Emi Kishino, Wataru Saitoh
|Dec 12, 2019
Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.Emi Kishino, Ryohei Ogata, Wataru Saitoh
|Feb 18, 2017
Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells.Junichi Kurebayashi, Yoshikazu Koike, Yusuke Ohta
|Oct 03, 2014
A case of adenomatous goiter involving diffuse, acute, and painful thyroid enlargement after fine-needle aspiration cytology.Toshiro Shimo, Katsuhiro Tanaka, Ryohei Ogata
Pageof 1
